MedTrace Logo

Investigation on the Epidemic Prevention Effect of Using Chinese Medicine During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Outbreak.

NCT05236309 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2022-03-02

No results posted yet for this study

Summary

Taking a regional hospital as an example, the investigators will discuss the changes in the community cumulative incidence rate(CIR) and the epidemic prevention effect of using Chinese medicine during the SARS-CoV-2 outbreak.

Main purpose:

Retrospective case study to explore the effect of traditional Chinese medicine on the prevention of SARS-CoV-2.

Secondary purpose:

If there are related side effects after taking Chinese medicine.

Conditions

  • COVID-19 Pandemic

Interventions

DRUG

Jing-Guan-Fang(JGF) : Chinese herbal decoction

Use 100ml JGF decoction per day as a preventive measure for patients with COVID-19.

Sponsors & Collaborators

  • Taipei City Hospital

    lead OTHER_GOV

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2021-07-31
Completion
2021-11-18

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05236309 on ClinicalTrials.gov